- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsing-Remitting Multiple Sclerosis (RRMS)
Total 3138 results
-
FibroBiologicsCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingMexico
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Mallinckrodt ARD LLCTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
University Hospital MuensterUnknownMultiple Sclerosis, Relapsing-RemittingGermany
-
GeNeuro SAWorldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...TerminatedMultiple Sclerosis, Relapsing-RemittingEstonia, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Poland, Russian Federation, Serbia, Spain, Ukraine
-
Rush University Medical CenterCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Belgium, Turkey, Bulgaria, United States, Czechia, Germany, Kuwait, Latvia, Lebanon
-
University Hospital MuensterBiogenCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Dokuz Eylul UniversityCompletedMultiple Sclerosis, Relapsing-RemittingTurkey
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Turkey, United States, Latvia, Lebanon, Germany, Belgium, Bulgaria, Czechia, Kuwait
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingItaly
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
Washington University School of MedicineBiogenWithdrawnMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Instituto Jalisciense de CancerologiaUniversity of Guadalajara; Instituto Mexicano del Seguro SocialUnknownMultiple Sclerosis, Relapsing-RemittingMexico
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Germany, Russian Federation, Spain, Poland
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-Remitting
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-RemittingDenmark
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-Remitting
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedMultiple Sclerosis, Relapsing-Remitting
-
Nelson Mandela Metropolitan UniversityUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-Remitting
-
TG Therapeutics, Inc.Active, not recruitingRelapsing Multiple Sclerosis (RMS)United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Multiple Sclerosis (RMS)Germany, Poland
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
University Hospital of Mont-GodinneSaint-Luc University HospitalRecruitingMultiple Sclerosis, Relapsing-RemittingBelgium
-
Kessler FoundationCelgene; Hackensack Meridian Health; St. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of NebraskaCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompleted
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingIndia, Trinidad and Tobago
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis, Relapsing-Remitting | Sexual DysfunctionUnited States
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Pontificia Universidade Católica do Rio Grande...Merck S.A., Brazil, an affiliate of Merck KGaA, Darmstadt, GermanyActive, not recruitingMultiple Sclerosis, Relapsing-RemittingBrazil
-
Massachusetts General HospitalGilead SciencesWithdrawnFatigue | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University of NottinghamNational Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
University of ReginaUniversity of Saskatchewan; Saskatchewan Health Research Foundation; First Steps...RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCanada
-
GlaxoSmithKlineTerminatedMultiple Sclerosis, Relapsing-RemittingItaly, Norway